We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.5B
AUM Growth
+$748M
Cap. Flow
+$681M
Cap. Flow %
45.46%
Top 10 Hldgs %
71.8%
Holding
659
New
195
Increased
97
Reduced
113
Closed
226

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$521M
2
IBB icon
iShares Biotechnology ETF
IBB
+$149M
3
LLY icon
Eli Lilly
LLY
+$74.8M
4
GILD icon
Gilead Sciences
GILD
+$60.9M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$15.7M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$21.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$17M
3
AVGO icon
Broadcom
AVGO
+$16.6M
4
MRVL icon
Marvell Technology
MRVL
+$14.3M
5
TMUS icon
T-Mobile US
TMUS
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.98%
2 Technology 3.97%
3 Financials 3.94%
4 Consumer Discretionary 2.88%
5 Industrials 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPN icon
176
Global Payments
GPN
$22.7B
$732K 0.05%
7,372
+5,417
+277% +$565K
TER icon
177
Teradyne
TER
$58.3B
$722K 0.05%
8,264
-9,562
-54% -$819K
ZD icon
178
Ziff Davis
ZD
$2.01B
$721K 0.05%
9,111
-2,855
-24% -$230K
WST icon
179
West Pharmaceutical
WST
$25.1B
$715K 0.05%
3,036
+1,519
+100% +$360K
LESL icon
180
Leslie's
LESL
$10.5M
$711K 0.05%
+2,912
New +$809K
F icon
181
Ford
F
$55B
$709K 0.05%
60,968
+888
+1% +$11.4K
IMMR icon
182
Immersion
IMMR
$255M
$691K 0.05%
98,243
+87,112
+783% +$561K
NTES icon
183
NetEase
NTES
$84.1B
$688K 0.05%
+9,474
New +$645K
ENTG icon
184
Entegris
ENTG
$22.7B
$684K 0.05%
+10,435
New +$768K
HLIT icon
185
Harmonic Inc
HLIT
$1.28B
$683K 0.05%
+52,172
New +$728K
RMD icon
186
ResMed
RMD
$31.5B
$674K 0.05%
+3,240
New +$712K
XRX icon
187
Xerox
XRX
$427M
$661K 0.04%
45,285
– –
PFGC icon
188
Performance Food Group
PFGC
$17.9B
$661K 0.04%
+11,312
New +$616K
ATRA icon
189
Atara Biotherapeutics
ATRA
$75.5M
$655K 0.04%
7,987
+106
+1% +$11K
ALLK
190
DELISTED
Allakos
ALLK
$655K 0.04%
77,773
– –
MRSH
191
Marsh
MRSH
$90.9B
$654K 0.04%
+3,954
New +$647K
VYGR icon
192
Voyager Therapeutics
VYGR
$201M
$651K 0.04%
106,696
-29,896
-22% -$170K
TSN icon
193
Tyson Foods
TSN
$20.2B
$646K 0.04%
+10,383
New +$675K
ADEA icon
194
Adeia
ADEA
$3.14B
$642K 0.04%
+67,771
New +$689K
KOD icon
195
Kodiak Sciences
KOD
$2.78B
$638K 0.04%
89,047
+31,386
+54% +$225K
ANIK icon
196
Anika Therapeutics
ANIK
$283M
$634K 0.04%
21,411
-22,393
-51% -$637K
STRO icon
197
Sutro Biopharma
STRO
$431M
$624K 0.04%
7,724
– –
OIS icon
198
Oil States International
OIS
$518M
$623K 0.04%
83,513
+42,531
+104% +$263K
MOMO
199
Hello Group
MOMO
$861M
$618K 0.04%
68,836
-48,132
-41% -$285K
GOTU icon
200
Gaotu Techedu
GOTU
$436M
$612K 0.04%
+259,318
New +$374K
6 7
8
9 10

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Associates (New York) held 659 positions worth $1.5B, up 100% from $751M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Caxton Associates (New York) deployed $681M of net new capital in Q4 2022, opening 195 new positions and adding to 97 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $21.3M trimmed.

  • Caxton Associates (New York)'s largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
  • Caxton Associates (New York) added most to Visa in Q4 2022, an estimated $13M increase.
  • Caxton Associates (New York)'s biggest Q4 2022 reduction was Amazon, cutting an estimated $21.3M.
  • Caxton Associates (New York) fully exited Broadcom in Q4 2022, selling an estimated $16.6M.
  • Caxton Associates (New York)'s ten largest holdings make up 72% of its $1.5B portfolio in Q4 2022.
  • Caxton Associates (New York) opened 195 new positions and closed 226 in Q4 2022.
  • Caxton Associates (New York)'s portfolio value rose 100% quarter-over-quarter to $1.5B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.